ORHB yields 2000000.00% · JNJ yields 2.13%● Live data
📍 ORHB pulled ahead of the other in Year 1
Combined, ORHB + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of ORHB + JNJ for your $10,000?
ORHub, Inc. provides surgical software focusing on real-time surgical data analytics. The company's suite of products serves the needs of the health care industry, hospitals, patients, the government, and medical device vendors. The company provides a cloud-based software solution that captures information before, during, and after surgery. Its software applications allow hospitals and medical device vendors to utilize Web-enabled device to create an anatomical graphic depiction during surgery. The company is based in Phoenix, Arizona.
Full ORHB Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.